Skip to main content
. 2019 Oct 11;47(5):1415–1427. doi: 10.1042/BST20190254

Figure 3. Dose–response curves for HTS hits against EPAC1-CNBD.

Figure 3.

The three hit compounds I178, I288, and I942 were tested in a seven-point dose–response curve in the EPAC1-CNBD, 8-NBD-cAMP-binding assay.